Literature DB >> 4625220

Hepatitis in dialysis units in the United Kingdom.

S Polakoff, Y E Cossart, H E Tillett.   

Abstract

A prospective study of hepatitis in 20 dialysis units in the United Kingdom showed that the number of units with outbreaks increased from one in 1968 to three in 1969 and the overall attack rate rose from 1.7 to 5.3% in patients and from 0.5 to 1.3% in staff.In July 1969 a pilot study of patients' sera showed that all of the outbreaks were associated with Australia (Au) antigen. Au antigen was not detected in the unaffected units or in one unit in which there were several patients with abnormal liver function.In January 1970 systematic prospective testing for Au antigen was begun. Au antigen was detected in single patients in five more of the 20 units. The transfer of the affected patients to isolation for dialysis seemed to prevent the spread of infection in the units. The incidence of hepatitis in 1970 was 5.6% in patients and 0.4% in staff.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4625220      PMCID: PMC1785592          DOI: 10.1136/bmj.3.5818.94

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Viral hepatitis. A staff hazard in dialysis units.

Authors:  P O Jones; H J Goldsmith; F K Wright; C Roberts; D C Watson
Journal:  Lancet       Date:  1967-04-15       Impact factor: 79.321

2.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

3.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

4.  Possible airborne spread of serum-hepatitis virus within a haemodialysis unit.

Authors:  J D Almeida; A E Kulatilake; D H Mackay; R Shackman; G D Chisholm; A B MacGregor; E P O'Donoghue; A P Waterson
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

5.  Hepatitis in a maintenance hemodialysis unit.

Authors:  J B Eastwood; J R Curtis; A J Wing; H E de Wardener
Journal:  Ann Intern Med       Date:  1968-07       Impact factor: 25.391

6.  S.H. antigen in haemodialysis-associated hepatitis.

Authors:  G C Turner; G B White
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

7.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

8.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

9.  An epidemic of hepatitis in a renal dialysis unit.

Authors:  R A Fox; A H Knight; S P Niazi; S Sherlock; R A Baillod; J F Moorhead
Journal:  Proc R Soc Med       Date:  1971-03

10.  Australia antigen in hemodialysis and renal transplantation units.

Authors:  M Leski; C Grivaux; A M Courouce-Pauty
Journal:  Vox Sang       Date:  1970 Sep-Oct       Impact factor: 2.144

  10 in total
  6 in total

1.  Experimental studies on environmental contamination with infected blood during haemodialysis.

Authors: 
Journal:  J Hyg (Lond)       Date:  1975-02

2.  Problems of protection against virus B hepatitis.

Authors:  S Polakoff
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

3.  Hepatitis.

Authors:  G C Turner
Journal:  Br Med J       Date:  1973-02-24

4.  In pursuit of safety.

Authors:  R E Williams
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

5.  e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.

Authors:  P E Gibson
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

6.  Hepatitis in dialysis units in the United Kingdom: a Public Health Laboratory Service Survey.

Authors:  S Polakoff
Journal:  J Hyg (Lond)       Date:  1981-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.